Nasdaq or NYSE related Biotechnology: Pharmaceutical Preparations industry Top Companies List by Market Cap as of January 2024

Nasdaq or NYSE listed Biotechnology: Pharmaceutical Preparations industry Top Companies List by Market Cap as of Jan-05-2024. Nasdaq and NYSE related Biotechnology: Pharmaceutical Preparations industry Largest Companies List by Market Cap as of Jan-05-2024

  1. Harmony Biosciences Holdings Inc.

    World Rank (Jan-05-2024)
    5,928
    Market Cap (Jan-05-2024)
    1.871 Billion USD
    World Rank (Jul-30-2023)
    5,534
    Market Cap (Jul-30-2023)
    2.111 Billion USD
    World Rank (Dec-25-2022)
    3,759
    Market Cap (Dec-25-2022)
    3.363 Billion USD
    World Rank (Jan-07-2022)
    5,877
    Market Cap (Jan-07-2022)
    2.22 Billion USD
    Annual Revenue in USD
    437 Million USD
    Annual Operating Income in USD
    120 Million USD
    Annual Net Income in USD
    181 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile

    Harmony Biosciences Holdings is a Pharmaceutical company. It focuses on disorders of sleep and wakefulness and currently working to advance the understanding of narcolepsy and provide information and resources to people who live with and healthcare professionals who treat, this chronic, debilitating neurologic disorder. The headquarters is in USA.

    Facts About Company

    The company annual revenue was 437 million USD and net income was 181 million USD as on 2022.

    Company Website
    HARMONY BIOSCIENCES HOLDINGS, INC.

  2. Viking Therapeutics

    World Rank (Jan-05-2024)
    5,954
    Market Cap (Jan-05-2024)
    1.859 Billion USD
    World Rank (Jul-30-2023)
    7,050
    Market Cap (Jul-30-2023)
    1.442 Billion USD
    World Rank (Dec-25-2022)
    10,811
    Market Cap (Dec-25-2022)
    0.648 Billion USD
    World Rank (Jan-07-2022)
    16,059
    Market Cap (Jan-07-2022)
    0.33 Billion USD
    Annual Revenue in USD
    0 Million USD
    Annual Operating Income in USD
    -70 Million USD
    Annual Net Income in USD
    -69 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Viking Therapeutics is a Clinical Stage Biopharmaceutical company. It is focused on the development of novel, orally available, first in class or best in class therapies for the treatment of metabolic and endocrine disorders. The company annual revenue is 7.3 million USD and 15 employees as 2019. The headquarters is in USA.
    Company Website
    VIKING THERAPEUTICS

  3. Catalyst Pharmaceuticals

    World Rank (Jan-05-2024)
    6,011
    Market Cap (Jan-05-2024)
    1.824 Billion USD
    World Rank (Jul-30-2023)
    6,873
    Market Cap (Jul-30-2023)
    1.501 Billion USD
    World Rank (Dec-25-2022)
    5,484
    Market Cap (Dec-25-2022)
    1.978 Billion USD
    World Rank (Jan-07-2022)
    11,623
    Market Cap (Jan-07-2022)
    0.68 Billion USD
    Annual Revenue in USD
    214 Million USD
    Annual Operating Income in USD
    101 Million USD
    Annual Net Income in USD
    83 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile

    Catalyst Pharmaceuticals is a Biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating neuromuscular and neurological diseases. The headquarters is in USA.

    Facts About Company

    Catalyst Pharmaceuticals Annual Total Revenue for year ending Dec-2022 was 214 million USD and and Net Income for year ending Dec-2022 was 83 million USD.

    Catalyst Pharmaceuticals Annual Total Revenue for year ending Dec-2021 was 140 million USD and and Net Income for year ending Dec-2021 was 39 million USD.

    As on 2022, Catalyst Pharmaceuticals has 82 employees.

    Company Website
    CATALYST PHARMACEUTICALS
    Wikipedia
    Wikipedia

  4. Amneal Pharmaceuticals

    World Rank (Jan-05-2024)
    6,045
    Market Cap (Jan-05-2024)
    1.809 Billion USD
    World Rank (Jul-30-2023)
    8,910
    Market Cap (Jul-30-2023)
    0.965 Billion USD
    World Rank (Dec-25-2022)
    15,083
    Market Cap (Dec-25-2022)
    0.333 Billion USD
    World Rank (Jan-07-2022)
    11,500
    Market Cap (Jan-07-2022)
    0.69 Billion USD
    Annual Revenue in USD
    2,212 Million USD
    Annual Operating Income in USD
    188 Million USD
    Annual Net Income in USD
    -129 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Yahoo @ NYSE
    Company Profile
    Amneal Pharmaceuticals is an Integrated Specialty Pharmaceutical company. It is powered by a robust U.S. generics business and a growing branded business and focused on delivering outcomes that meet important medical needs, make quality medicines more accessible and more affordable and provide solutions for tomorrows health challenges. The headquarters is in USA.
    Company Website
    AMNEAL PHARMACEUTICALS INC

  5. Inhibrx Inc.

    World Rank (Jan-05-2024)
    6,046
    Market Cap (Jan-05-2024)
    1.809 Billion USD
    World Rank (Jul-30-2023)
    7,998
    World Rank (Dec-25-2022)
    7,998
    Market Cap (Dec-25-2022)
    1.081 Billion USD
    World Rank (Jan-07-2022)
    8,138
    Market Cap (Jan-07-2022)
    1.29 Billion USD
    Annual Revenue in USD
    7,125 Million USD
    Annual Net Income in USD
    -81 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Inhibrx is a Clinical Stage Biotechnology company developed a diverse pipeline of therapeutic candidates specifically designed to leverage the power of core sdAb (single-domain antibody) platform and protein engineering expertise. The company annual revenue is 34.1 million USD and 80 employees as on 2020. The headquarters is in USA.
    Company Website
    INHIBRX, INC.

  6. Syndax Pharmaceuticals

    World Rank (Jan-05-2024)
    6,088
    Market Cap (Jan-05-2024)
    1.788 Billion USD
    World Rank (Jul-30-2023)
    6,989
    Market Cap (Jul-30-2023)
    1.461 Billion USD
    World Rank (Dec-25-2022)
    6,132
    Market Cap (Dec-25-2022)
    1.655 Billion USD
    World Rank (Jan-07-2022)
    9,280
    Market Cap (Jan-07-2022)
    1.03 Billion USD
    Annual Revenue in USD
    0 Million USD
    Annual Operating Income in USD
    -151 Million USD
    Annual Net Income in USD
    -149 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Syndax Pharmaceuticals is a Clinical Stage Biopharmaceutical company developing an innovative pipeline of cancer therapies. The company annual revenue is 1.5 million USD and 38 employees as on 2019. The headquarters is in USA.
    Company Website
    SYNDAX PHARMACEUTICALS

  7. AbCellera Biologics Inc.

    World Rank (Jan-05-2024)
    6,216
    Market Cap (Jan-05-2024)
    1.724 Billion USD
    World Rank (Jul-30-2023)
    5,362
    Market Cap (Jul-30-2023)
    2.220 Billion USD
    World Rank (Dec-25-2022)
    4,125
    Market Cap (Dec-25-2022)
    2.955 Billion USD
    World Rank (Jan-07-2022)
    4,491
    Market Cap (Jan-07-2022)
    3.33 Billion USD
    Annual Revenue in USD
    288 Million USD
    Annual Net Income in USD
    118 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Canada
    Company Profile
    ABCELLERA BIOLOGICS INC. is Biotechnology sector company with headquarters is in Vancouver, Canada.
    Company Website
    ABCELLERA BIOLOGICS INC.
    Wikipedia
    Wikipedia

  8. Tilray

    World Rank (Jan-05-2024)
    6,251
    Market Cap (Jan-05-2024)
    1.705 Billion USD
    World Rank (Jul-30-2023)
    6,746
    Market Cap (Jul-30-2023)
    1.546 Billion USD
    World Rank (Dec-25-2022)
    7,371
    Market Cap (Dec-25-2022)
    1.245 Billion USD
    World Rank (Jan-07-2022)
    4,786
    Market Cap (Jan-07-2022)
    3.05 Billion USD
    Annual Revenue in USD
    483 Million USD
    Annual Net Income in USD
    -366 Million USD
    Annual Results for Period Ending
    May-2022 ending year
    Headquarters Country
    Canada
    Yahoo @ Nasdaq
    Company Profile
    Tilray is a Cannabis Research, Cultivation, Processing and Distribution company. It first GMP-certified medical cannabis producer to supply cannabis flower and extract products to tens of thousands of patients, physicians, pharmacies, hospitals, governments and researchers on five continents. The headquarters is in Canada.
    Company Website
    TILRAY

  9. Maravai LifeSciences Holdings Inc.

    World Rank (Jan-05-2024)
    6,533
    Market Cap (Jan-05-2024)
    1.596 Billion USD
    World Rank (Jul-30-2023)
    4,497
    Market Cap (Jul-30-2023)
    2.874 Billion USD
    World Rank (Dec-25-2022)
    5,741
    Market Cap (Dec-25-2022)
    1.838 Billion USD
    World Rank (Jan-07-2022)
    3,616
    Market Cap (Jan-07-2022)
    4.40 Billion USD
    Annual Revenue in USD
    883 Million USD
    Annual Operating Income in USD
    566 Million USD
    Annual Net Income in USD
    220 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile

    Maravai LifeSciences Holdings is a biotechnology sector company related to providing products and services into the fields of nucleic acid production, biologics safety testing and protein detection to many of the worlds leading biopharma, vaccine, diagnostics, and cell and gene therapy companies. It has 390 employees as on 2019. The headquarters is in USA.

    Company Website
    MARAVAI LIFESCIENCES HOLDINGS, INC.

  10. Taro Pharmaceutical Industries

    World Rank (Jan-05-2024)
    6,615
    Market Cap (Jan-05-2024)
    1.562 Billion USD
    World Rank (Jul-30-2023)
    7,238
    Market Cap (Jul-30-2023)
    1.379 Billion USD
    World Rank (Dec-25-2022)
    7,898
    Market Cap (Dec-25-2022)
    1.107 Billion USD
    World Rank (Jan-07-2022)
    6,638
    Market Cap (Jan-07-2022)
    1.83 Billion USD
    Annual Revenue in USD
    561 Million USD
    Annual Net Income in USD
    58 Million USD
    Annual Results for Period Ending
    Mar-2022 ending year
    Headquarters Country
    USA
    Yahoo @ NYSE
    Company Profile
    Taro Pharmaceutical Industries is a Research Based International Pharmaceutical company. The headquarters is in USA.
    Company Website
    TARO PHARMACEUTICAL INDUSTRIES LTD.

Share